secwatch / observer
8-K filed April 24, 2026, 7:59 PM ET ticker MDCX CIK 0001997296
regulatory confidence high sentiment negative materiality 0.75

Medicus Pharma Ltd. (MDCX): Nasdaq/NYSE listing notice — Medicus Pharma receives Nasdaq bid price deficiency notice; expands ATM to $50M

Medicus Pharma Ltd.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Medicus Pharma Ltd. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
April 21, 2026, the Company received written notice (the "Notice") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that the closing bid price for the Company's
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Medicus Pharma Ltd. amended Equity Distribution Agreement with Maxim Group LLC and Yorkville Securities, LLC valued at up to $50,000,000 (effective 2026-04-23).

Action
amendment
Agreement
atm program
Counterparty
Maxim Group LLC and Yorkville Securities, LLC
Value
up to $50,000,000
Effective
2026-04-23
Exact text from the filing
the Company and the Agents entered into Amendment No. 1 to the Agreement (the "First Amendment", and together with the Agreement, the "Amended Agreement"), pursuant to which the Company increased the size of the aggregate offering amount from $15,349,674 to up to $50,000,000 (the "ATM Upsize")
View on SEC.gov

8 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Medicus Pharma Ltd. filing history →

Source: SEC EDGAR
accession 0001062993-26-002142
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.